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a2 .2-Globulin Nephropathy in
White Ravens
In a recent article in Scientific American,
Woodward and Goodstein (1) discussed
the handling ofdata that do not support a
given hypothesis. They illustrated their
point as follows:
an investigator might inductively infer,
after observing a large number of black
ravens, that all ravens are black. According
to the inductive approach, good scientific
practice consists in recording all that one
observes and not just some selected part of
it. The guiding ideal is to avoid any error
that might slip in as a result ofprejudice or
preconception.
Later, the authors discussed the falsifi-
cationist ideas ofKarl Popper in relation to
the black ravens: "the observation ofa sin-
gle nonblack raven will falsify the hypothe-
sis that all ravens are black."
Huff (2) recently discussed the role of
cell proliferation in chemical carcinogene-
sis. At one point he discussed the ability of
certain putatively nongenotoxic chemicals
to induce renal cancer in male rats. The
section in question is worth quoting in frill.
Meanwhile regulators and administrators
should continue to be considerably cau-
tious before embracing a purported mecha-
nism-even a reasonable proposed hypo-
thetical mechanism of carcinogenesis-as
being pivotal to public health decisions.
One example still garnering considerable
debate centers on whether chemicals that
induce cancers of the tubular cell epitheli-
um ofthe kidney in male rats, concomitant
with an increase in cell proliferation and
testosterone-mediated ca-2p-globulin pro-
tein are relevant or useful to overall hazard
identification for humans. The U.S.
Environmental Protection Agency (for
example) has embraced the concept that
these experimental carcinogenic responses
are not important to the human situation,
whereas others (e.g., the Interational
Agency for Research on Cancer) appear
properly cautious, or have proposed equally
reasonable alternative hypotheses. For
example, and yet to be clarified, there are
several chemicals known to induce this spe-
cific nephropathy syndrome that do not
cause kidney cancers, and may or may not
produce cancers in other organs; this lack
ofconsistency must be explained.
Huff has seen some white ravens, but
he has not identified them for other inter-
ested parties to study. I too have heard
similar rumors, but I have yet to see a con-
vening of the chemical structure, genetic
toxicity, hyalin droplet data, and adequate
rat cancer bioassay data for such a chemi-
cal. Given the importance of the issue
under discusion, it would be valuable if
Huff were to identify the chemicals to
which he referred and present the relevant
data for them in a focused paper. This
would enable the commissioning of
research to elucidate whether the a2p-
globulin male rat renal cancer hypothesis
should be retained or abandoned. Equally,
when the available data are scrutinized,
and perhaps extended, it may be possible
to retain the hypothesis for use under qual-
ified conditions; for example, it may be
concluded that the persistence or magni-
tude ofthe nephropathy, as opposed to its
presence, is the critical parameter.
The surest way to make progress in
assessment of the hazard posed to humans
by rodent carcinogens is for exceptions to
current models to be clearly identified and
made the subject ofactive research. In the
absence of a range ofvalid models, there
will be only one: namely, that the rodent
carcinogens dibenzanthracene and sodium
saccharin present the same intrinsic car-
cinogenic hazard to humans.
JohnAshby
Zeneca Central Toxicology Laboratory
Alderley Park, Cheshire, United Kingdom
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Response: a2p-Globulin
Nephropathy, Posed
Mechanisms, and White
Ravens
In our zest to discover the holy grail(s) of
chemical carcinogenesis-read mecha-
nism(s)-we seem to have short circuited
the time-honed pattern of Koch's path of
finding/proving scientific truth. As I
understand the scientific paradigm of dis-
covery, one must exhaust and counter all
possible exceptions to the purported
hypothesis before accepting the conjecture
as truth. Further, if one exception to the
rule persists-white ravens-then the
hypothesis is either untrue or, at the most,
must be modified to accommodate the
uncertainty introduced by the exception. If
several and varied exceptions exist, then
the putative mechanism must be aban-
doned or be considered very limited in
validity or application. Ashby (1) proposes
that "it may be possible to retain the
hypothesis for use under qualified condi-
tions." Ideally, I have little difficulty with
his suggestion; however, in practice, the
workability of such nuances is nearly
impossible. Recall that "as it happens often
in science, a timid suggestion at the end of
a discussion, a carefully worded hypothesis,
become transformed in the next paper
(often by other authors) into a fact" (2).
Perhaps this is what happened to the a2p-
globulin hypothesis, without the attendant
necessary search for white ravens. Some
have associated this testosterone-mediated
protein with tumors ofthe kidney-in male
rats. Importantly, a plausible rationale has
yet to be offered to explain why certain
a2p-globulin-provoking chemicals fail to
systematically induce renal tubular cell
tumors. Early on, in fact, several ofus have
raised basic issues about this purported
mechanism (3-5).
Hence, from my personal perspective
in the sensitive area of human health and
life, one must ignore the scientific urge to
retain such tentative and "footnoted"
hypotheses because proof, acceptance, and
utilization for public health purposes must
remain sacrosanct and on a firm founda-
tion, especially when the use ofsaid limit-
ed proofallows greater potential risks to be
propagated or perpetrated. Nonetheless,
the search for mechanisms ofcarcinogene-
sis-likely to be chemical specific-must
continue.
In this vein, Ashby (1) urges me to
identify the white ravens in the a2p-globu-
lin story. As that earlier paper, from which
Ashby generously quotes my writing, was a
more broadened view of the visible white
ravens in the overall hypothesis of chemi-
cally induced cell proliferation and cancer
(6), I did not identify the specific chemical
exceptions to the a2p-globulin hypothesis.
I had given the names of those chemicals
in previous papers (7,8) and did not think
them particularly relevant in the cell prolif-
eration paper quoted by Ashby. Further, I
certainly believed that those professing the
strength of the a2p-globulin hypothesis
would have been aware of these excep-
tions-aware ofthem and either explained
the discrepancies or simply discounted
them. In this communication, the chemi-
cals that disobey the a2p-globulin hypoth-
esis are given.
I am pleased for the opportunity to list
these chemicals, together with brief
explanatory passages for each. So far, there
are at least four chemicals that instigate the
a2p-globulin-syndrome yet do not induce
tumors of the kidney in male rats:
gabapentin, an antiepileptic drug; lindane,
an insecticide; decalin, a solvent; and
trimethylpentane, the prototypical a2p-
globulin inducer present in gasoline.
Additionally, another chemical induces the
a2p-globulin sequela but causes two differ-
ent cellular rypes of tumors of the kidney
(dimethyl methylphosphonate). One
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